MarketBeat Instant News Alerts MarketBeat Instant News Alerts - Page 20 September 24, 2026 7:00 AM ETWedbush Reiterates "Neutral" Rating for Roku (NASDAQ:ROKU)MarketBeatNASDAQ:ROKURead Wedbush Reiterates "Neutral" Rating for Roku (NASDAQ:ROKU)September 24, 2026 6:42 AM ETEupraxia Pharmaceuticals (NASDAQ:EPRX) Coverage Initiated at WedbushMarketBeatNASDAQ:EPRXRead Eupraxia Pharmaceuticals (NASDAQ:EPRX) Coverage Initiated at WedbushSeptember 24, 2026 6:42 AM ETScotiabank Cuts W.P. Carey (NYSE:WPC) Price Target to $68.00MarketBeatNYSE:WPCRead Scotiabank Cuts W.P. Carey (NYSE:WPC) Price Target to $68.00September 24, 2026 6:42 AM ETScotiabank Lowers NETSTREIT (NYSE:NTST) Price Target to $20.00MarketBeatNYSE:NTSTRead Scotiabank Lowers NETSTREIT (NYSE:NTST) Price Target to $20.00September 24, 2026 6:42 AM ETEssential Properties Realty Trust (NYSE:EPRT) Given New $30.00 Price Target at ScotiabankMarketBeatNYSE:EPRTRead Essential Properties Realty Trust (NYSE:EPRT) Given New $30.00 Price Target at ScotiabankSeptember 24, 2026 6:36 AM ETEverpure (NYSE:P) Price Target Raised to $145.00 at Wells Fargo & CompanyMarketBeatNYSE:PRead Everpure (NYSE:P) Price Target Raised to $145.00 at Wells Fargo & CompanySeptember 24, 2026 6:36 AM ETWells Fargo & Company Boosts Okta (NASDAQ:OKTA) Price Target to $230.00MarketBeatNASDAQ:OKTARead Wells Fargo & Company Boosts Okta (NASDAQ:OKTA) Price Target to $230.00September 24, 2026 6:14 AM ETCVS Group plc (LON:CVSG) Receives Average Rating of "Moderate Buy" from BrokeragesMarketBeatLON:CVSGRead CVS Group plc (LON:CVSG) Receives Average Rating of "Moderate Buy" from BrokeragesSeptember 24, 2026 6:12 AM ETAC Immune's (ACIU) "Buy" Rating Reaffirmed at BTIG ResearchMarketBeatNASDAQ:ACIURead AC Immune's (ACIU) "Buy" Rating Reaffirmed at BTIG ResearchSeptember 24, 2026 6:12 AM ETTheravance Biopharma (NASDAQ:TBPH) Receives Neutral Rating from BTIG ResearchMarketBeatNASDAQ:TBPHRead Theravance Biopharma (NASDAQ:TBPH) Receives Neutral Rating from BTIG ResearchSeptember 24, 2026 6:12 AM ETPraxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at Needham & Company LLCMarketBeatNASDAQ:PRAXRead Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at Needham & Company LLCSeptember 24, 2026 6:12 AM ETBTIG Research Issues Pessimistic Forecast for McDonald's (NYSE:MCD) Stock PriceMarketBeatNYSE:MCDRead BTIG Research Issues Pessimistic Forecast for McDonald's (NYSE:MCD) Stock PriceSeptember 24, 2026 6:12 AM ETBooking (NASDAQ:BKNG) Receives "Buy" Rating from BTIG ResearchMarketBeatNASDAQ:BKNGRead Booking (NASDAQ:BKNG) Receives "Buy" Rating from BTIG ResearchSeptember 24, 2026 6:12 AM ETAmericas Gold and Silver (NYSEAMERICAN:USAS) Given Buy Rating at HC WainwrightMarketBeatNYSEAMERICAN:USASRead Americas Gold and Silver (NYSEAMERICAN:USAS) Given Buy Rating at HC WainwrightSeptember 24, 2026 6:12 AM ETTyler Technologies' (TYL) Buy Rating Reaffirmed at BTIG ResearchMarketBeatNYSE:TYLRead Tyler Technologies' (TYL) Buy Rating Reaffirmed at BTIG ResearchSeptember 24, 2026 6:12 AM ETBank of America Initiates Coverage on MGE Energy (NASDAQ:MGEE)MarketBeatNASDAQ:MGEERead Bank of America Initiates Coverage on MGE Energy (NASDAQ:MGEE)September 24, 2026 6:12 AM ETCantor Fitzgerald Reiterates "Overweight" Rating for Dycom Industries (NYSE:DY)MarketBeatNYSE:DYRead Cantor Fitzgerald Reiterates "Overweight" Rating for Dycom Industries (NYSE:DY)September 24, 2026 6:12 AM ETEverpure (NYSE:P) Price Target Raised to $150.00 at Needham & Company LLCMarketBeatNYSE:PRead Everpure (NYSE:P) Price Target Raised to $150.00 at Needham & Company LLCSeptember 24, 2026 6:12 AM ETAlmonty Industries (NASDAQ:ALM) Earns Neutral Rating from Analysts at The Goldman Sachs GroupMarketBeatNASDAQ:ALMRead Almonty Industries (NASDAQ:ALM) Earns Neutral Rating from Analysts at The Goldman Sachs GroupSeptember 24, 2026 6:12 AM ETFervo Energy's (FRVO) Outperform Rating Reaffirmed at Sanford C. BernsteinMarketBeatNASDAQ:FRVORead Fervo Energy's (FRVO) Outperform Rating Reaffirmed at Sanford C. BernsteinSeptember 24, 2026 6:12 AM ETAurora Innovation's (AUR) Buy Rating Reiterated at Needham & Company LLCMarketBeatNASDAQ:AURRead Aurora Innovation's (AUR) Buy Rating Reiterated at Needham & Company LLCSeptember 24, 2026 6:12 AM ETIonis Pharmaceuticals (NASDAQ:IONS) Receives Buy Rating from HC WainwrightMarketBeatNASDAQ:IONSRead Ionis Pharmaceuticals (NASDAQ:IONS) Receives Buy Rating from HC WainwrightSeptember 24, 2026 6:12 AM ETNeedham & Company LLC Reaffirms "Buy" Rating for NeoVolta (NASDAQ:NEOV)MarketBeatNASDAQ:NEOVRead Needham & Company LLC Reaffirms "Buy" Rating for NeoVolta (NASDAQ:NEOV)September 24, 2026 6:12 AM ETMaze Therapeutics' (MAZE) Buy Rating Reaffirmed at HC WainwrightMarketBeatNASDAQ:MAZERead Maze Therapeutics' (MAZE) Buy Rating Reaffirmed at HC Wainwright Featured Articles and OffersNVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In ItBy Bridget Bennett | September 20, 2026Major Buy Alert Issued for September 30thFrom TradeSmith (Ad)The AI Bottleneck Is Not Chips Anymore and 3 Pipeline Stocks Are Cashing InBy Bridget Bennett | September 20, 2026Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?By Thomas Hughes | September 21, 2026Generac Plugs Into Amazon for an $8B AI-Powered DealBy Jeffrey Neal Johnson | September 18, 2026Shocking new footage just releasedFrom Digest Publishing (Ad)Braze Beat Expectations—Now 2 SaaS Peers Are in FocusBy Nathan Reiff | September 18, 2026Meta’s Muse Highlights Arm’s Growing Role in AI InfrastructureBy Jeffrey Neal Johnson | September 22, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 20 of 216 « Most Recent‹ More Recent17181920212223 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
